Title : Effect of the novel oral dipeptidyl peptidase IV inhibitor vildagliptin on the pharmacokinetics and pharmacodynamics of warfarin in healthy subjects.

Pub. Date : 2007 May

PMID : 17519080






3 Functional Relationships(s)
Download
Sentence
Compound Name
Protein Name
Organism
1 Effect of the novel oral dipeptidyl peptidase IV inhibitor vildagliptin on the pharmacokinetics and pharmacodynamics of warfarin in healthy subjects. Vildagliptin dipeptidyl peptidase 4 Homo sapiens
2 OBJECTIVE: Vildagliptin is a potent and selective dipeptidyl peptidase-IV (DPP-4) inhibitor that improves glycemic control in patients with type 2 diabetes by increasing alpha and beta-cell responsiveness to glucose. Vildagliptin dipeptidyl peptidase 4 Homo sapiens
3 OBJECTIVE: Vildagliptin is a potent and selective dipeptidyl peptidase-IV (DPP-4) inhibitor that improves glycemic control in patients with type 2 diabetes by increasing alpha and beta-cell responsiveness to glucose. Vildagliptin dipeptidyl peptidase 4 Homo sapiens